“It was first understood as our main defense against opioid overdose,” Nguyen said. “The issue is that for some time, the FDA had not granted the approval of over-the-counter, non-prescription use of Naloxone because I think the standards for treating opioid overdoses were still being developed.”
Trending
- Baylor student turns family recipe into small business
- Baylor soccer secures No. 2 seed in NCAA tournament for 2nd time
- Baylor men’s tennis features doubles pair, 3 singles in NCAA Individual Championships
- Performance Nutrition aims to fuel football on field, in relationships
- Medical humanities professors defend religion over superstition on faculty panel
- Texas Monthly’s Daniel Vaughn shares stories behind the barbecue
- Cinnamon, espresso, kindness: How Be Kind crafts best-selling Churro Latte
- Sweet trip ‘Around The World’: Local bakery serves international treats

